Development and use of machine learning algorithms in vaccine target selection

B Bravi - npj Vaccines, 2024 - nature.com
Computer-aided discovery of vaccine targets has become a cornerstone of rational vaccine
design. In this article, I discuss how Machine Learning (ML) can inform and guide key …

Structure-based methods for binding mode and binding affinity prediction for peptide-MHC complexes

DA Antunes, JR Abella, D Devaurs… - Current topics in …, 2018 - ingentaconnect.com
Understanding the mechanisms involved in the activation of an immune response is
essential to many fields in human health, including vaccine development and personalized …

Structural dissimilarity from self drives neoepitope escape from immune tolerance

JR Devlin, JA Alonso, CM Ayres, GLJ Keller… - Nature chemical …, 2020 - nature.com
T-cell recognition of peptides incorporating nonsynonymous mutations, or neoepitopes, is a
cornerstone of tumor immunity and forms the basis of new immunotherapy approaches …

Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals

I Quiros-Fernandez, M Poorebrahim, E Fakhr… - …, 2021 - thelancet.com
Background Recent studies have provided evidence of T cell reactivity to Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in significant numbers of non-infected …

PANDORA: a fast, anchor-restrained modelling protocol for peptide: MHC complexes

DF Marzella, FM Parizi, D Tilborg, N Renaud… - Frontiers in …, 2022 - frontiersin.org
Deeper understanding of T-cell-mediated adaptive immune responses is important for the
design of cancer immunotherapies and antiviral vaccines against pandemic outbreaks. T …

HLA3DB: comprehensive annotation of peptide/HLA complexes enables blind structure prediction of T cell epitopes

S Gupta, S Nerli, S Kutti Kandy, GL Mersky… - Nature …, 2023 - nature.com
The class I proteins of the major histocompatibility complex (MHC-I) display epitopic
peptides derived from endogenous proteins on the cell surface for immune surveillance …

Uncovering the tumor antigen landscape: what to know about the discovery process

S Feola, J Chiaro, B Martins, V Cerullo - Cancers, 2020 - mdpi.com
According to the latest available data, cancer is the second leading cause of death,
highlighting the need for novel cancer therapeutic approaches. In this context …

APE-Gen2. 0: Expanding Rapid Class I Peptide–Major Histocompatibility Complex Modeling to Post-Translational Modifications and Noncanonical Peptide …

R Fasoulis, MM Rigo, G Lizée… - Journal of Chemical …, 2024 - ACS Publications
The recognition of peptides bound to class I major histocompatibility complex (MHC-I)
receptors by T-cell receptors (TCRs) is a determinant of triggering the adaptive immune …

Viral molecular mimicry influences the antitumor immune response in murine and human melanoma

J Chiaro, HHE Kasanen, T Whalley, C Capasso… - Cancer immunology …, 2021 - AACR
Molecular mimicry is one of the leading mechanisms by which infectious agents can induce
autoimmunity. Whether a similar mechanism triggers an antitumor immune response is …

Interpreting T-cell cross-reactivity through structure: implications for TCR-based cancer immunotherapy

DA Antunes, MM Rigo, MV Freitas… - Frontiers in …, 2017 - frontiersin.org
Immunotherapy has become one of the most promising avenues for cancer treatment,
making use of the patient's own immune system to eliminate cancer cells. Clinical trials with …